156 related articles for article (PubMed ID: 32996568)
21. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
22. The association between histological subtypes and lymph node metastasis and prognosis in early esophageal cancer: a population-based study.
Lin JP; Chen XF; Zhou H; Zhuang FN; He H; Chen WJ; Wang F; Liu SY
Eur J Cancer Prev; 2024 Mar; 33(2):152-160. PubMed ID: 37991237
[TBL] [Abstract][Full Text] [Related]
23. Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis.
Yamashita K; Watanabe M; Mine S; Toihata T; Fukudome I; Okamura A; Yuda M; Hayami M; Ishizuka N; Imamura Y
Surg Endosc; 2018 Nov; 32(11):4443-4450. PubMed ID: 29644466
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Outcomes Between McKeown and Sweet Esophagectomy in the Elderly Patients for Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.
Chen D; Hu Y; Chen Y; Hu J; Wen Z
Cancer Control; 2020; 27(1):1073274820904700. PubMed ID: 32048521
[TBL] [Abstract][Full Text] [Related]
25. Comparing survival between neoadjuvant chemoradiotherapy followed by open or thoracoscopic oesophagectomy in patients with oesophageal squamous cell carcinoma.
Chen HS; Lin CH; Wu SC; Wang BY
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35303068
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients.
Warnecke-Eberz U; Plum P; Schweinsberg V; Drebber U; Bruns CJ; Müller DT; Hölscher AH; Bollschweiler E
World J Gastroenterol; 2020 Jun; 26(23):3236-3248. PubMed ID: 32684738
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
28. Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis.
Worrell SG; Towe CW; A Dorth J; Machtay M; Perry Y; Linden PA
Ann Surg Oncol; 2020 Feb; 27(2):500-508. PubMed ID: 31571054
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant Therapy Versus Upfront Surgery for Patients With Clinical Stage 2 or 3 Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
Gao X; Wen YW; van Lanschot JJB; Chao YK
Ann Surg Oncol; 2022 Jun; 29(6):3644-3653. PubMed ID: 35018592
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma.
Hsu PK; Chen HS; Liu CC; Wu SC
Ann Surg Oncol; 2019 Feb; 26(2):506-513. PubMed ID: 30430325
[TBL] [Abstract][Full Text] [Related]
32. Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Hsu PK; Chen HS; Liu CC; Huang CS; Hsieh CC; Hsu HS; Wu SC
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):732-740.e2. PubMed ID: 28457536
[TBL] [Abstract][Full Text] [Related]
33. A Comparative Analysis of the Gene Expression Profiles of Small Cell Esophageal Carcinoma, Small Cell Lung Cancer, and Esophageal Adeno/Squamous Carcinoma.
Liu D; Wen J; Chen J; Wang B; Xu X; Zhang Z; Fan M
Front Surg; 2021; 8():655159. PubMed ID: 34395507
[No Abstract] [Full Text] [Related]
34. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
36. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
[TBL] [Abstract][Full Text] [Related]
37. Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma.
Solomon D; Abbas M; Feferman Y; Haddad R; Perl G; Kundel Y; Morgenstern S; Menasherov N; Kashtan H
Ann Surg Oncol; 2021 Sep; 28(9):4929-4940. PubMed ID: 33709175
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes following minimally invasive and open esophagectomy in Finland: A population-based study.
Sihvo E; Helminen O; Gunn J; Sipilä JOT; Rautava P; Kytö V
Eur J Surg Oncol; 2019 Jun; 45(6):1099-1104. PubMed ID: 30553631
[TBL] [Abstract][Full Text] [Related]
39. The correlation between high body mass index and survival in patients with esophageal cancer after curative esophagectomy: evidence from retrospective studies.
Pan W; Sun Z; Xiang Y; Fang W
Asia Pac J Clin Nutr; 2015; 24(3):480-8. PubMed ID: 26420190
[TBL] [Abstract][Full Text] [Related]
40. Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis.
Luo HS; Xu HY; Du ZS; Li XY; Wu SX; Huang HC; Lin LX
Radiat Oncol; 2019 May; 14(1):74. PubMed ID: 31046792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
